Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa
Condition: Meningococcal Infection (Healthy Volunteers) Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine; Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine; Biological: Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV); Biologica l: Pneumoccocal Vaccine; Biological: Measles, Mumps, and Rubella Vaccine live (MMR); Biological: DTwP-HepB-Hib-IPV vaccine; Biological: DTaP-IPV-Hib-HepB vaccine; Biological: Hepatitis A vaccine; Biological: Rotavirus vaccine; Biological: Typhoid conjugate vaccine (T CV); Biological: Measles vaccine; Biological: Varicella vaccine live Sponsor: Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: ActHIB | African Health | Diphtheria | India Health | Measles | Measles Vaccine | Men | Meningitis | Meningitis Vaccine | Mumps | Mumps Vaccine | Pediatrics | Pneomococcal Vaccine | Polio | Polio Vaccine | Research | Rubella | Rubella Vaccine | South Africa Health | Study | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Vaccines